Impact of Risk Minimisation Measures on the Use of Strontium Ranelate: A Multi‐National Cohort Study in 5 EU Countries by the EU‐ADR Alliance

Aug-17

AUTHORS : Dr M.Sanni Ali, Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, NDORMS, University of Oxford, Botnar Research Centre, Windmill Road , Oxford OX3 7LD , UK – Email: sanni.ali@lshtm.ac.uk / sanni.ali@ndorms.ox.ac.uk – Profile: https://www.medsci.ox.ac.uk/study/graduateschool/supervisors/sanni-ali

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 26(S2):483

DOI : 10.1002/pds.4275

Impact of Risk Minimisation Measures on the Use of Strontium Ranelate: A Multi‐National Cohort Study in 5 EU Countries by the EU‐ADR Alliance

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study